Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects

David Vauzour, David Vauzour

Abstract

Accumulating evidence suggests that diet and lifestyle can play an important role in delaying the onset or halting the progression of age-related health disorders and to improve cognitive function. In particular, polyphenols have been reported to exert their neuroprotective actions through the potential to protect neurons against injury induced by neurotoxins, an ability to suppress neuroinflammation, and the potential to promote memory, learning, and cognitive function. Despite significant advances in our understanding of the biology of polyphenols, they are still mistakenly regarded as simply acting as antioxidants. However, recent evidence suggests that their beneficial effects involve decreases in oxidative/inflammatory stress signaling, increases in protective signaling and neurohormetic effects leading to the expression of genes that encode antioxidant enzymes, phase-2 enzymes, neurotrophic factors, and cytoprotective proteins. Specific examples of such pathways include the sirtuin-FoxO pathway, the NF-κB pathway, and the Nrf-2/ARE pathway. Together, these processes act to maintain brain homeostasis and play important roles in neuronal stress adaptation and thus polyphenols have the potential to prevent the progression of neurodegenerative pathologies.

Figures

Figure 1
Figure 1
Structures of polyphenols. Polyphenols are a group of naturally occurring phytochemicals which are present in high amounts in fruits, vegetables, and natural products and are characterised by the presence of multiple hydroxyl groups on aromatic rings. These compounds are divided into two main categories, the flavonoids and non flavonoids, based on the number of phenol rings and the way in which these rings interact. For the flavonoid group, the major differences between the individual groups arise from the hydroxylation pattern of the ring-structure, the degree of saturation of the C-ring, and the substitution of the 3-position. HBAs, hydroxybennzoic acids; HCAs, hydroxycinammic acids.
Figure 2
Figure 2
Modulation of neuronal dysfunction by dietary polyphenols. In ageing and neurodegenerative diseases, neuronal death can be triggered by specific genetic mutations, neurotoxins, and/or neuroinflammation. Initiating factors promote cellular alterations, including increases in oxidative stress, protein aggregation, DNA damage, and activation of apoptotic cascades. Dietary polyphenols have been observed to protect the brain against such cellular alteration through the modulation of neuronal function against endogenous neurotoxins and inhibition of glial-induced neuroinflammation. Aβ, amyloid beta; CysDA, 5-S-cysteinyldopamine; DHBT1, dihydrobenzothiazine 1; TNF-α, tumor necrosis factor alpha; IL-1β, interleukine-1 beta; CRP, C reactive protein; NO, nitric oxide.
Figure 3
Figure 3
Mechanisms underlying the biological effects of polyphenols. Polyphenols and their in vivo metabolites activate cellular stress-response pathways resulting in the upregulation of neuroprotective genes. For example, both PKC and ERK can activate the nuclear factor erythroid 2-related factor 2 (Nrf2). Nrf2 then translocates to the nucleus and binds to the antioxidant response element (ARE) in genes that encode cytoprotective proteins such as antioxidant enzymes (AOE) and phase 2 (Ph2) enzymes. The transcription factor cAMP-response-element-binding protein (CREB) is also activated by ERK, which induces the expression of brain-derived neurotrophic factor (BDNF), a mediator of neurohormesis. In addition, polyphenols can also regulate the transcription factor NF-κB, which can mediate adaptive cellular stress responses by reducing the expression of inflammatory cytokines. Activated SIRT1 may also inhibit NF-κB and so can reduce the cellular stress response. Another important pathway activated by metabolic and oxidative stress involves transcription factors of the forkhead (FoxO) family, which modulate genes that encode antioxidant enzymes and other stress-response proteins.

References

    1. WHO. Mediumterm strategic plan 2008–2013 and propopsed programme budget 2008-2009, Geneva, Switzerland, Word Health Organisation, 2007.
    1. Jellinger KA, Stadelmann C. Problems of cell death in neurodegeneration and Alzheimer’s disease. Journal of Alzheimer’s Disease. 2001;3(1):31–40.
    1. Barzilai A, Melamed E. Molecular mechanisms of selective dopaminergic neuronal death in Parkinson’s disease. Trends in Molecular Medicine. 2003;9(3):126–132.
    1. Spires TL, Hyman BT. Transgenic models of Alzheimer’s disease: learning from animals. NeuroRx. 2005;2(3):423–437.
    1. Letenneur L, Proust-Lima C, Le Gouge A, Dartigues JF, Barberger-Gateau P. Flavonoid intake and cognitive decline over a 10-year period. American Journal of Epidemiology. 2007;165(12):1364–1371.
    1. Beking K, Vieira A. Flavonoid intake and disability-adjusted life years due to Alzheimers and related dementias: a population-based study involving twenty-three developed countries. Public Health Nutrition. 2010;13(9):1403–1409.
    1. Chan YC, Hosoda K, Tsai CJ, Yamamoto S, Wang MF. Favorable effects of tea on reducing the cognitive deficits and brain morphological changes in senescence-accelerated mice. Journal of Nutritional Science and Vitaminology. 2006;52(4):266–273.
    1. Haque AM, Hashimoto M, Katakura M, Tanabe Y, Hara Y, Shido O. Long-term administration of green tea catechins improves spatial cognition learning ability in rats. Journal of Nutrition. 2006;136(4):1043–1047.
    1. Kaur T, Pathak CM, Pandhi P, Khanduja KL. Effects of green tea extract on learning, memory, behavior and acetylcholinesterase activity in young and old male rats. Brain and Cognition. 2008;67(1):25–30.
    1. Oliveira DR, Sanada PF, Saragossa FAC, et al. Neuromodulatory property of standardized extract Ginkgo biloba L. (EGb 761) on memory: behavioral and molecular evidence. Brain Research. 2009;1269(C):68–89.
    1. Shif O, Gillette K, Damkaoutis CM, Carrano C, Robbins SJ, Hoffman JR. Effects of Ginkgo biloba administered after spatial learning on water maze and radial arm maze performance in young adult rats. Pharmacology Biochemistry and Behavior. 2006;84(1):17–25.
    1. Field DT, Williams CM, Butler LT. Consumption of cocoa flavanols results in an acute improvement in visual and cognitive functions. Physiology and Behavior. 2011;103(3-4):255–260.
    1. Scholey AB, French SJ, Morris PJ, Kennedy DO, Milne AL, Haskell CF. Consumption of cocoa flavanols results in acute improvements in mood and cognitive performance during sustained mental effort. Journal of Psychopharmacology. 2010;24(10):1505–1514.
    1. Casadesus G, Shukitt-Hale B, Stellwagen HM, et al. Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats. Nutritional Neuroscience. 2004;7(5-6):309–316.
    1. Shukitt-Hale B, Lau FC, Carey AN, et al. Blueberry polyphenols attenuate kainic acid-induced decrements in cognition and alter inflammatory gene expression in rat hippocampus. Nutritional Neuroscience. 2008;11(4):172–182.
    1. Williams CM, El Mohsen MA, Vauzour D, et al. Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radical Biology and Medicine. 2008;45(3):295–305.
    1. Datla KP, Christidou M, Widmer WW, Rooprai HK, Dexter DT. Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson’s disease. NeuroReport. 2001;12(17):3871–3875.
    1. Bastianetto S, Zheng WH, Quirion R. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. British Journal of Pharmacology. 2000;131(4):711–720.
    1. Williams RJ, Spencer JPE, Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free Radical Biology and Medicine. 2004;36(7):838–849.
    1. Calabrese V, Cornelius C, Dinkova-Kostova AT, et al. Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochimica et Biophysica Acta. 2012;1822(5):753–783.
    1. Herrmann K. Occurrence and content of hydroxycinnamic and hydroxybenzoic acid compounds in foods. Critical Reviews in Food Science and Nutrition. 1989;28(4):315–347.
    1. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. American Journal of Clinical Nutrition. 2004;79(5):727–747.
    1. Fleuriet A, Macheix J. Phenolic acids in fruits. In: Rice-Evans CA, Packer L, editors. Flavonoids in Health and Disease. New York, NY, USA: Marcel Dekker; 1998. pp. 35–59.
    1. Clifford MN. Chlorogenic acids and other cinnamates—nature, occurrence, dietary burden, absorption and metabolism. Journal of the Science of Food and Agriculture. 2000;80(7):1033–1043.
    1. Langcake P. Disease resistance of vitis spp and the production of the stress metabolites resveratrol, epsilon-viniferin, alpha-viniferin and pterostilbene. Physiological Plant Pathology. 1981;18(2):213–226.
    1. Langcake P, Pryce RJ. The production of resveratrol and the viniferins by grapevines in response to ultraviolet irradiation. Phytochemistry. 1977;16(8):1193–1196.
    1. Crozier A, Jaganath IB, Clifford MN. Dietary phenolics: chemistry, bioavailability and effects on health. Natural Product Reports. 2009;26(8):1001–1043.
    1. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. The American Journal of Clinical Nutrition. 2005;81(supplement 1):230S–242S.
    1. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. The American Journal of Clinical Nutrition. 2005;81(1):243S–255S.
    1. Abbott NJ, Patabendige AAK, Dolman DEM, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiology of Disease. 2010;37(1):13–25.
    1. Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C. Interaction between flavonoids and the blood-brain barrier: in vitro studies. Journal of Neurochemistry. 2003;85(1):180–192.
    1. Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radical Biology and Medicine. 2004;36(5):592–604.
    1. Faria A, Pestana D, Teixeira D, et al. Insights into the putative catechin and epicatechin transport across blood-brain barrier. Food and Function. 2011;2(1):39–44.
    1. Peng HW, Cheng FC, Huang YT, Chen CF, Tsai TH. Determination of naringenin and its glucuronide conjugate in rat plasma and brain tissue by high-performance liquid chromatography. Journal of Chromatography B. 1998;714(2):369–374.
    1. Suganuma M, Okabe S, Oniyama M, Tada Y, Ito H, Fujiki H. Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis. 1998;19(10):1771–1776.
    1. Abd El Mohsen MM, Kuhnle G, Rechner AR, et al. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radical Biology and Medicine. 2002;33(12):1693–1702.
    1. El Mohsen MA, Marks J, Kuhnle G, et al. Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats. British Journal of Nutrition. 2006;95(1):51–58.
    1. Talavéra S, Felgines C, Texier O, et al. Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and brain. Journal of Agricultural and Food Chemistry. 2005;53(10):3902–3908.
    1. Fridén M, Ljungqvist H, Middleton B, Bredberg U, Hammarlund-Udenaes M. Improved measurement of drug exposure in the brain using drug-specific correction for residual blood. Journal of Cerebral Blood Flow and Metabolism. 2010;30(1):150–161.
    1. Schaffer S, Halliwell B. Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations. Genes & Nutrition. 2012;7(2):99–109.
    1. Passamonti S, Vrhovsek U, Vanzo A, Mattivi F. Fast access of some grape pigments to the brain. Journal of Agricultural and Food Chemistry. 2005;53(18):7029–7034.
    1. Kalt W, Blumberg JB, McDonald JE, et al. Identification of anthocyanins in the liver, eye, and brain of blueberry-fed pigs. Journal of Agricultural and Food Chemistry. 2008;56(3):705–712.
    1. Milbury PE, Kalt W. Xenobiotic metabolism and berry flavonoid transport across the blood? Brain barrier. Journal of Agricultural and Food Chemistry. 2010;58(7):3950–3956.
    1. Janle EM, Lila MA, Grannan M, et al. Pharmacokinetics and tissue distribution of 14C-Labeled grape polyphenols in the periphery and the central nervous system following oral administration. Journal of Medicinal Food. 2010;13(4):926–933.
    1. Commenges D, Scotet V, Renaud S, Jacqmin-Gadda H, Barberger-Gateau P, Dartigues JF. Intake of flavonoids and risk of dementia. European Journal of Epidemiology. 2000;16(4):357–363.
    1. Spencer JPE. Food for thought: the role of dietary flavonoids in enhancing human memory, learning and neuro-cognitive performance. Proceedings of the Nutrition Society. 2008;67(2):238–252.
    1. Spencer JPE. Flavonoids: modulators of brain function? British Journal of Nutrition. 2008;99(1):ES60–ES77.
    1. Nurk E, Refsum H, Drevon CA, et al. Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance1-3. Journal of Nutrition. 2009;139(1):120–127.
    1. Beking K, Vieira A. Flavonoid intake and disability-adjusted life years due to Alzheimers and related dementias: a population-based study involving twenty-three developed countries. Public Health Nutrition. 2010;13(9):1403–1409.
    1. Kesse-Guyot E, Fezeu L, Andreeva VA, et al. Total and specific polyphenol intakes in midlife are associated with cognitive function measured 13 years later. Journal of Nutrition. 2012;142(1):76–83.
    1. Barberger-Gateau P, Raffaitin C, Letenneur L, et al. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology. 2007;69(20):1921–1930.
    1. Joseph JA, Shukitt-Hale B, Denisova NA, et al. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. Journal of Neuroscience. 1999;19(18):8114–8121.
    1. Crews WD, Jr., Harrison DW, Griffin ML, et al. A double-blinded, placebo-controlled, randomized trial of the neuropsychologic efficacy of cranberry juice in a sample of cognitively intact older adults: pilot study findings. Journal of Alternative and Complementary Medicine. 2005;11(2):305–309.
    1. Krikorian R, Nash TA, Shidler MD, Shukitt-Hale B, Joseph JA. Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment. British Journal of Nutrition. 2010;103(5):730–734.
    1. Krikorian R, Shidler MD, Nash TA, et al. Blueberry supplementation improves memory in older adults. Journal of Agricultural and Food Chemistry. 2010;58(7):3996–4000.
    1. Goyarzu P, Malin DH, Lau FC, et al. Blueberry supplemented diet: effects on object recognition memory and nuclear factor-kappa B levels in aged rats. Nutritional Neuroscience. 2004;7(2):75–83.
    1. Barros D, Amaral OB, Izquierdo I, et al. Behavioral and genoprotective effects of Vaccinium berries intake in mice. Pharmacology Biochemistry and Behavior. 2006;84(2):229–234.
    1. Ramirez MR, Izquierdo I, Bassols Raseira MDC, Zuanazzi JÂ, Barros D, Henriques AT. Effect of lyophilised Vaccinium berries on memory, anxiety and locomotion in adult rats. Pharmacological Research. 2005;52(6):457–462.
    1. Burke SN, Barnes CA. Neural plasticity in the ageing brain. Nature Reviews Neuroscience. 2006;7(1):30–40.
    1. Stangl D, Thuret S. Impact of diet on adult hippocampal neurogenesis. Genes and Nutrition. 2009;4(4):271–282.
    1. Patel AK, Rogers JT, Huang X, et al. Flavanols, mild cognitive impairment, and Alzheimer's dementia. International Journal of Clinical and Experimental Medicine. 2008;1(2):181–191.
    1. van Praag H, Lucero MJ, Yeo GW, et al. Plant-derived flavanol (-)epicatechin enhances angiogenesis and retention of spatial memory in mice. Journal of Neuroscience. 2007;27(22):5869–5878.
    1. Schroeter H, Heiss C, Balzer J, et al. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(4):1024–1029.
    1. Heiss C, Dejam A, Kleinbongard P, Schewe T, Sies H, Kelm M. Vascular effects of cocoa rich in flavan-3-ols. Journal of the American Medical Association. 2003;290(8):1030–1031.
    1. Heiss C, Finis D, Kleinbongard P, et al. Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week. Journal of Cardiovascular Pharmacology. 2007;49(2):74–80.
    1. Sorond FA, Lipsitz LA, Hollenberg NK, Fisher NDL. Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans. Neuropsychiatric Disease and Treatment. 2008;4(2):433–440.
    1. Francis ST, Head K, Morris PG, Macdonald IA. The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. Journal of Cardiovascular Pharmacology. 2006;47(2):S215–S220.
    1. Gage FH. Mammalian neural stem cells. Science. 2000;287(5457):1433–1438.
    1. Zhao C, Deng W, Gage FH. Mechanisms and functional implications of adult neurogenesis. Cell. 2008;132(4):645–660.
    1. Palmer TD, Willhoite AR, Gage FH. Vascular niche for adult hippocampal neurogenesis. The Journal of Comparative Neurology. 2000;425(4):479–494.
    1. Cohen-Salmon C, Venault P, Martin B, et al. Effects of Ginkgo biloba extract (EGb 761) on learning and possible actions on aging. Journal of Physiology Paris. 1997;91(6):291–300.
    1. Diamond BJ, Shiflett SC, Feiwel N, et al. Ginkgo biloba extract: mechanisms and clinical indications. Archives of Physical Medicine and Rehabilitation. 2000;81(5):668–678.
    1. Itil TM, Eralp E, Ahmed I, Kunitz A, Itil KZ. The pharmacological effects of Ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine. Psychopharmacology Bulletin. 1998;34(3):391–397.
    1. Hoffman JR, Donato A, Robbins SJ. Ginkgo biloba promotes short-term retention of spatial memory in rats. Pharmacology Biochemistry and Behavior. 2004;77(3):533–539.
    1. Wang Y, Wang L, Wu J, Cai J. The in vivo synaptic plasticity mechanism of EGb 761-induced enhancement of spatial learning and memory in aged rats. British Journal of Pharmacology. 2006;148(2):147–153.
    1. Oyama Y, Chikahisa L, Ueha T, Kanemaru K, Noda K. Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Research. 1996;712(2):349–352.
    1. Gajewski A, Hensch SA. Ginkgo biloba and memory for a maze. Psychological Reports. 1999;84(2):481–484.
    1. Stoll S, Scheuer K, Pohl O, Müller WE. Ginkgo biloba extract (EGb 761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse. Pharmacopsychiatry. 1996;29(4):144–149.
    1. Chopin P, Briley M. Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats. Psychopharmacology. 1992;106(1):26–30.
    1. Ramassamy C, Clostre F, Christen Y, Costentin J. Prevention by a Ginkgo biloba extract (GBE 761) of the dopaminergic neurotoxicity of MPTP. Journal of Pharmacy and Pharmacology. 1990;42(11):785–789.
    1. Watanabe CMH, Wolffram S, Ader P, et al. The in vivo neuromodulatory effects of the herbal medicine Ginkgo biloba. Proceedings of the National Academy of Sciences of the United States of America. 2001;98(12):6577–6580.
    1. Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WT, Jr., Swanson PD. Parkinson’s disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. American Journal of Epidemiology. 2002;155(8):732–738.
    1. Walsh DM, Selkoe DJ. Aβ oligomers—a decade of discovery. Journal of Neurochemistry. 2007;101(5):1172–1184.
    1. Yan JJ, Cho JY, Kim HS, et al. Protection against β-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. British Journal of Pharmacology. 2001;133(1):89–96.
    1. Rezai-Zadeh K, Arendash GW, Hou H, et al. Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Research. 2008;1214(C):177–187.
    1. Li Q, Zhao HF, Zhang ZF, et al. Long-term green tea catechin administration prevents spatial learning and memory impairment in senescence-accelerated mouse prone-8 mice by decreasing Aβ1-42 oligomers and upregulating synaptic plasticity-related proteins in the hippocampus. Neuroscience. 2009;163(3):741–749.
    1. Ono K, Yoshiike Y, Takashima A, Hasegawa K, Naiki H, Yamada M. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer’s disease. Journal of Neurochemistry. 2003;87(1):172–181.
    1. Ono K, Condron MM, Ho L, et al. Effects of grape seed-derived polyphenols on amyloid β-protein self-assembly and cytotoxicity. Journal of Biological Chemistry. 2008;283(47):32176–32187.
    1. Hirohata M, Hasegawa K, Tsutsumi-Yasuhara S, et al. The anti-amyloidogenic effect is exerted against Alzheimer’s β-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure. Biochemistry. 2007;46(7):1888–1899.
    1. Onozuka H, Nakajima A, Matsuzaki K, et al. Nobiletin, a citrus flavonoid, improves memory impairment and Aβ pathology in a transgenic mouse model of Alzheimer’s disease. Journal of Pharmacology and Experimental Therapeutics. 2008;326(3):739–744.
    1. Fernandez JW, Rezai-Zadeh K, Obregon D, Tan J. EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP. FEBS Letters. 2010;584(19):4259–4267.
    1. Rezai-Zadeh K, Shytle D, Sun N, et al. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. Journal of Neuroscience. 2005;25(38):8807–8814.
    1. Mandel SA, Amit T, Kalfon L, Reznichenko L, Weinreb O, Youdim MBH. Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG) Journal of Alzheimer’s Disease. 2008;15(2):211–222.
    1. Amit T, Avramovich-Tirosh Y, Youdim MBH, Mandel S. Targeting multiple Alzheimer’s disease etiologies with multimodal neuroprotective and neurorestorative iron chelators. The FASEB Journal. 2008;22(5):1296–1305.
    1. Mandel S, Amit T, Bar-Am O, Youdim MBH. Iron dysregulation in Alzheimer’s disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents. Progress in Neurobiology. 2007;82(6):348–360.
    1. Ehrnhoefer DE, Bieschke J, Boeddrich A, et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nature Structural and Molecular Biology. 2008;15(6):558–566.
    1. Mori T, Rezai-Zadeh K, Koyama N, et al. Tannic acid is a natural beta-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice. The Journal of Biological Chemistry. 2012;287(9):6912–6927.
    1. Williams RJ, Spencer JP. Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radical Biology & Medicine. 2012;52(1):35–45.
    1. Mandel S, Youdim MBH. Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radical Biology and Medicine. 2004;37(3):304–317.
    1. Weinreb O, Mandel S, Amit T, Youdim MBH. Neurological mechanisms of green tea polyphenols in Alzheimer’s and Parkinson’s diseases. Journal of Nutritional Biochemistry. 2004;15(9):506–516.
    1. Mandel SA, Amit T, Weinreb O, Youdim MBH. Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and neurodegenerative diseases. Journal of Alzheimer’s Disease. 2011;25(2):187–208.
    1. Levites Y, Youdim MBH, Maor G, Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-κB) activation and cell death by tea extracts in neuronal cultures. Biochemical Pharmacology. 2002;63(1):21–29.
    1. Levites Y, Weinreb O, Maor G, Youdim MBH, Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. Journal of Neurochemistry. 2001;78(5):1073–1082.
    1. Spencer JPE, Whiteman M, Jenner P, Halliwell B. 5-S-cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons. Journal of Neurochemistry. 2002;81(1):122–129.
    1. Vauzour D, Ravaioli G, Vafeiadou K, Rodriguez-Mateos A, Angeloni C, Spencer JPE. Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyl-dopamine and DHBT-1: implications for Parkinson’s disease and protection by polyphenols. Archives of Biochemistry and Biophysics. 2008;476(2):145–151.
    1. Vauzour D, Corona G, Spencer JPE. Caffeic acid, tyrosol and p-coumaric acid are potent inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity. Archives of Biochemistry and Biophysics. 2010;501(1):106–111.
    1. Vauzour D, Vafeiadou K, Spencer JPE. Inhibition of the formation of the neurotoxin 5-S-cysteinyl-dopamine by polyphenols. Biochemical and Biophysical Research Communications. 2007;362(2):340–346.
    1. Li H, Dryhurst G. Oxidative metabolites of 5-S-cysteinyldopamine inhibit the pyruvate dehydrogenase complex. Journal of Neural Transmission. 2001;108(12):1363–1374.
    1. Hirsch EC, Hunot S, Hartmann A. Neuroinflammatory processes in Parkinson’s disease. Parkinsonism and Related Disorders. 2005;11(supplement 1):S9–S15.
    1. Agostinho P, Cunha RA, Oliveira C. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer’s disease. Current Pharmaceutical Design. 2010;16(25):2766–2778.
    1. Praticò D, Trojanowski JQ. Inflammatory hypotheses: novel mechanisms of Alzheimer’s neurodegeneration and new therapeutic targets? Neurobiology of Aging. 2000;21(3):441–445.
    1. Ceulemans AG, Zgavc T, Kooijman R, Hachimi-Idrissi S, Sarre S, Michotte Y. The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. Journal of Neuroinflammation. 2010;7, article 74
    1. Stewart VC, Heales SJR. Nitric oxide-induced mitochondrial dysfunction: implications for neurodegeneration. Free Radical Biology and Medicine. 2003;34(3):287–303.
    1. Moncada S, Bolaños JP. Nitric oxide, cell bioenergetics and neurodegeneration. Journal of Neurochemistry. 2006;97(6):1676–1689.
    1. Qin L, Liu Y, Wang T, et al. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. Journal of Biological Chemistry. 2004;279(2):1415–1421.
    1. Bal-Price A, Matthias A, Brown GC. Stimulation of the NADPH oxidase in activated rat microglia removes nitric oxide but induces peroxynitrite production. Journal of Neurochemistry. 2002;80(1):73–80.
    1. Abramov AY, Jacobson J, Wientjes F, Hothersall J, Canevari L, Duchen MR. Expression and modulation of an NADPH oxidase in mammalian astrocytes. Journal of Neuroscience. 2005;25(40):9176–9184.
    1. Brown GC, Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Molecular Neurobiology. 2003;27(3):325–355.
    1. MacEwan DJ. TNF receptor subtype signalling: differences and cellular consequences. Cellular Signalling. 2002;14(6):477–492.
    1. Taylor DL, Jones F, Chen Seho Kubota ESF, Pocock JM. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor α-induced neurotoxicity in concert with microglial-derived Fas ligand. Journal of Neuroscience. 2005;25(11):2952–2964.
    1. Szekely CA, Thorne JE, Zandi PP, et al. Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer’s disease: a systematic review. Neuroepidemiology. 2004;23(4):159–169.
    1. González-Gallego J, García MV, Sánchez-Campos S, Tuñó MJ. Fruit polyphenols, immunity and inflammation. British Journal of Nutrition. 2010;104(supplement 3):S15–S27.
    1. Spencer JP, Vafeiadou K, Williams RJ, Vauzour D. Neuroinflammation: modulation by flavonoids and mechanisms of action. Molecular Aspects of Medicine. 2012;33(1):83–97.
    1. Kao TK, Ou YC, Raung SL, Lai CY, Liao SL, Chen CJ. Inhibition of nitric oxide production by quercetin in endotoxin/cytokine-stimulated microglia. Life Sciences. 2010;86(9-10):315–321.
    1. Sharma V, Mishra M, Ghosh S, et al. Modulation of interleukin-1β mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection. Brain Research Bulletin. 2007;73(1–3):55–63.
    1. Bureau G, Longpré F, Martinoli MG. Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. Journal of Neuroscience Research. 2008;86(2):403–410.
    1. Vafeiadou K, Vauzour D, Lee HY, Rodriguez-Mateos A, Williams RJ, Spencer JPE. The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Archives of Biochemistry and Biophysics. 2009;484(1):100–109.
    1. Lau FC, Bielinski DF, Joseph JA. Inhibitory effects of blueberry extract on the production of inflammatory mediators in lipopolysaccharide-activated BV2 microglia. Journal of Neuroscience Research. 2007;85(5):1010–1017.
    1. Steffen Y, Gruber C, Schewe T, Sies H. Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Archives of Biochemistry and Biophysics. 2008;469(2):209–219.
    1. Martino G, Adorini L, Rieckmann P, et al. Inflammation in multiple sclerosis: the good, the bad, and the complex. Lancet Neurology. 2002;1(8):499–509.
    1. Aktas O, Prozorovski T, Smorodchenko A, et al. Green tea epigallocatechin-3-gallate mediates T cellular NF-κB inhibition and exerts neuroprotection in autoimmune encephalomyelitis. Journal of Immunology. 2004;173(9):5794–5800.
    1. Muthian G, Bright JJ. Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte. Journal of Clinical Immunology. 2004;24(5):542–552.
    1. Imler TJ, Jr., Petro TM. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4− IFN-γ+ cells, and decreased macrophage IL-6 expression. International Immunopharmacology. 2009;9(1):134–143.
    1. Halliwell B. Oxidative stress and neurodegeneration: where are we now? Journal of Neurochemistry. 2006;97(6):1634–1658.
    1. Pannala AS, Rice-Evans CA, Halliwell B, Singh S. Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. Biochemical and Biophysical Research Communications. 1997;232(1):164–168.
    1. Russo A, Acquaviva R, Campisi A, et al. Bioflavonoids as antiradicals, antioxidants and DNA cleavage protectors. Cell Biology and Toxicology. 2000;16(2):91–98.
    1. Visioli F, Bellomo G, Galli C. Free radical-scavenging properties of olive oil polyphenols. Biochemical and Biophysical Research Communications. 1998;247(1):60–64.
    1. Schroeter H, Bahia P, Spencer JPE, et al. (-)Epicatechin stimulates ERK-dependent cyclic AMP response element activity and up-regulates GluR2 in cortical neurons. Journal of Neurochemistry. 2007;101(6):1596–1606.
    1. Schroeter H, Spencer JPE, Rice-Evans C, Williams RJ. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochemical Journal. 2001;358(3):547–557.
    1. Vauzour D, Vafeiadou K, Rice-Evans C, Williams RJ, Spencer JPE. Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. Journal of Neurochemistry. 2007;103(4):1355–1367.
    1. Mattson MP, Cheng A. Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses. Trends in Neurosciences. 2006;29(11):632–639.
    1. Calabrese EJ. Neuroscience and hormesis: overview and general findings. Critical Reviews in Toxicology. 2008;38(4):249–252.
    1. Kraft AD, Johnson DA, Johnson JA. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. Journal of Neuroscience. 2004;24(5):1101–1112.
    1. Lee JM, Johnson JA. An important role of Nrf2-ARE pathway in the cellular defense mechanism. Journal of Biochemistry and Molecular Biology. 2004;37(2):139–143.
    1. Itoh K, Wakabayashi N, Katoh Y, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes and Development. 1999;13(1):76–86.
    1. Nguyen T, Sherratt PJ, Pickett CB. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annual Review of Pharmacology and Toxicology. 2003;43:233–260.
    1. Chen CY, Jang JH, Li MH, Surh YJ. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochemical and Biophysical Research Communications. 2005;331(4):993–1000.
    1. Ren J, Fan C, Chen N, Huang J, Yang Q. Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. Neurochemical Research. 2011;36(12):2352–2362.
    1. Kurauchi Y, Hisatsune A, Isohama Y, Mishima S, Katsuki H. Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving heme oxygenase-1 and brain-derived neurotrophic factor. British Journal of Pharmacology. In press.
    1. Scapagnini G, Butterfield DA, Colombrita C, Sultana R, Pascale A, Calabrese V. Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress. Antioxidants and Redox Signaling. 2004;6(5):811–818.
    1. Shah ZA, Li RC, Ahmad AS, et al. The flavanol (-)-epicatechin prevents stroke damage through the Nrf2/HO1 pathway. Journal of Cerebral Blood Flow and Metabolism. 2010;30(12):1951–1961.
    1. Bahia PK, Rattray M, Williams RJ. Dietary flavonoid (-)epicatechin stimulates phosphatidylinositol 3-kinase-dependent anti-oxidant response element activity and up-regulates glutathione in cortical astrocytes. Journal of Neurochemistry. 2008;106(5):2194–2204.
    1. Boesch-Saadatmandi C, Niering J, Minihane AM, et al. Impact of apolipoprotein E genotype and dietary quercetin on paraoxonase 1 status in apoE3 and apoE4 transgenic mice. Atherosclerosis. 2010;211(1):110–113.
    1. Boesch-Saadatmandi C, Wolffram S, Minihane AM, Rimbach G. Effect of apoE genotype and dietary quercetin on blood lipids and TNF-α levels in apoE3 and apoE4 targeted gene replacement mice. British Journal of Nutrition. 2009;101(10):1440–1443.
    1. Egert S, Boesch-Saadatmandi C, Wolffram S, Rimbach G, Müller MJ. Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. Journal of Nutrition. 2010;140(2):278–284.
    1. Graeser AC, Boesch-Saadatmandi C, Lippmann J, et al. Nrf2-dependent gene expression is affected by the proatherogenic apoE4 genotype-studies in targeted gene replacement mice. Journal of Molecular Medicine. 2011;89(10):1027–1035.
    1. Impey S, Smith DM, Obrietan K, Donahue R, Wade C, Storm DR. Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning. Nature Neuroscience. 1998;1(7):595–601.
    1. Bourtchuladze R, Frenguelli B, Blendy J, Cioffi D, Schutz G, Silva AJ. Deficient long-term memory in mice with a targeted mutation of the cAMP- responsive element-binding protein. Cell. 1994;79(1):59–68.
    1. Finkbeiner S. CREB couples neurotrophin signals to survival messages. Neuron. 2000;25(1):11–14.
    1. Tully T, Bourtchouladze R, Scott R, Tallman J. Targeting the creb pathway for memory enhancers. Nature Reviews Drug Discovery. 2003;2(4):267–277.
    1. Finkbeiner S, Tavazoie SF, Maloratsky A, Jacobs KM, Harris KM, Greenberg ME. CREB: a major mediator of neuronal neurotrophin responses. Neuron. 1997;19(5):1031–1047.
    1. Kong ANT, Yu R, Chen C, Mandlekar S, Primiano T. Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Archives of Pharmacal Research. 2000;23(1):1–16.
    1. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) Journal of Biological Chemistry. 1994;269(7):5241–5248.
    1. Schratt GM, Nigh EA, Chen WG, Hu L, Greenberg ME. BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. Journal of Neuroscience. 2004;24(33):7366–7377.
    1. Yin Y, Edelman GM, Vanderklish PW. The brain-derived neurotrophic factor enhances synthesis of Arc in synaptoneurosomes. Proceedings of the National Academy of Sciences of the United States of America. 2002;99(4):2368–2373.
    1. Waltereit R, Dammermann B, Wulff P, et al. Arg3.1/Arc mRNA induction by Ca2+ and cAMP requires protein kinase a and mitogen-activated protein kinase/extracellular regulated kinase activation. Journal of Neuroscience. 2001;21(15):5484–5493.
    1. Levites Y, Amit T, Youdim MBH, Mandel S. Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. Journal of Biological Chemistry. 2002;277(34):30574–30580.
    1. Ito H, Sun XL, Watanabe M, Okamoto M, Hatano T. Chlorogenic acid and its metabolite m-coumaric acid evoke neurite outgrowth in hippocampal neuronal cells. Bioscience, Biotechnology and Biochemistry. 2008;72(3):885–888.
    1. Reznichenko L, Amit T, Youdim MBH, Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate induces neurorescue of long-term serum-deprived PC12 cells and promotes neurite outgrowth. Journal of Neurochemistry. 2005;93(5):1157–1167.
    1. Camandola S, Mattson MP. NF-κB as a therapeutic target in neurodegenerative diseases. Expert Opinion on Therapeutic Targets. 2007;11(2):123–132.
    1. Zhang F, Qian L, Flood PM, Shi JS, Hong JS, Gao HM. Inhibition of IκB kinase-β protects dopamine neurons against lipopolysaccharide-induced neurotoxicity. Journal of Pharmacology and Experimental Therapeutics. 2010;333(3):822–833.
    1. Liang YC, Huang YT, Tsai SH, Lin-Shiau SY, Chen CF, Lin JK. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis. 1999;20(10):1945–1952.
    1. Huang Q, Wu LJ, Tashiro SI, Gao HY, Onodera S, Ikejima T. (+)-catechin, an ingredient of green tea, protects murine microglia from oxidative stress-induced DNA damage and cell cycle arrest. Journal of Pharmacological Sciences. 2005;98(1):16–24.
    1. Kim H, Kim YS, Kim SY, Suk K. The plant flavonoid wogonin suppresses death of activated C6 rat glial cells by inhibiting nitric oxide production. Neuroscience Letters. 2001;309(1):67–71.
    1. Dell’Albani P, Santangelo R, Torrisi L, Nicoletti VG, De Vellis J, Giuffrida Stella AM. JAK/STAT signaling pathway mediates cytokine-induced iNOS expression in primary astroglial cell cultures. Journal of Neuroscience Research. 2001;65(5):417–424.
    1. Suk K, Lee H, Kang SS, Cho GJ, Choi WS. Flavonoid baicalein attenuates activation-induced cell death of brain microglia. Journal of Pharmacology and Experimental Therapeutics. 2003;305(2):638–645.
    1. Spilsbury A, Vauzour D, Spencer JP, Rattray M. Regulation of NF-κB activity in astrocytes: effects of flavonoids at dietary-relevant concentrations. Biochemical and Biophysical Research Communications. 2012;418(3):578–583.
    1. Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochemical Journal. 2007;404(1):1–13.
    1. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444(7117):337–342.
    1. Knutson MD, Leeuwenburgh C. Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases. Nutrition Reviews. 2008;66(10):591–596.
    1. Baur JA. Resveratrol, sirtuins, and the promise of a DR mimetic. Mechanisms of Ageing and Development. 2010;131(4):261–269.
    1. Park SJ, Ahmad F, Philp A, et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell. 2012;148(3):421–433.
    1. Tang BL, Chua CEL. SIRT1 and neuronal diseases. Molecular Aspects of Medicine. 2008;29(3):187–200.
    1. Parker JA, Arango M, Abderrahmane S, et al. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nature Genetics. 2005;37(4):349–350.
    1. Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. The EMBO Journal. 2004;23(12):2369–2380.
    1. Crozier A, Del Rio D, Clifford MN, et al. Bioavailability of dietary flavonoids and phenolic compounds. Molecular Aspects of Medicine. 2010;31(6):446–467.
    1. Williamson G, Clifford MN. Colonic metabolites of berry polyphenols: the missing link to biological activity? British Journal of Nutrition. 2010;104(supplement 3):S48–S66.

Source: PubMed

3
Subscribe